Skip to content

Dr. Helen Sheldrake

Assistant Professor

Area
School of Pharmacy & Medical Sciences
Faculty of Life Sciences
E-mail
Phone
Dr. Helen Sheldrake

Biography

Helen Sheldrake studied Natural Sciences followed by a PhD in natural product synthesis at the University of Cambridge. After postdoctoral work at The University of Manchester, she joined the Institute of Cancer Therapeutics, University of Bradford as a RCUK Academic Fellow in Medicinal Chemistry. She is now a Lecturer in the School of Pharmacy and Medical Sciences, and School Health and Safety Lead.

Research

New synthetic methods for biologically active/druglike molecules. Design and synthesis of integrin antagonists. Total synthesis.

The integrins are a family of transmembrane receptors which mediate cell-cell and cell-ECM adhesion, and signalling across the cell membrane involved in pathways controlling cell migration, proliferation, differentiation, cell survival and apoptosis. In cancers, their vital role in the cross-talk between the cell and extracellular matrix enhances the growth, migration, invasion and metastasis of cancer cells. The RGD-binding subfamily of integrins are of particular interest as anticancer targets, since there is strong evidence that their expression in cancers is correlated with tumour progression, treatment resistance, and a cancer stem cell phenotype. Research areas currently under investigation include:

  • Investigation of combination therapies to combat integrin-mediated resistance to existing anticancer agents
  • Targeted integrin degradation
  • Synthesis and characterisation of new integrin targeting small molecules for the treatment of advanced cancers, particularly metastatic prostate cancer and malignant melanoma.
  •  Synthesis of biologically active natural products, and derivatives. Current targets include Nigramide Q and Scopariusicides A-C.

Postgraduate Supervision

Currently Dr Sheldrake is supervisor to the following postgraduate students:

Name: Reuben McKay

Contact details: r.c.mckay@bradford.ac.uk

Project outline: Reuben’s current research uses enamine cyclisation reactions to explore analogues of natural products with potential antibacterial and anticancer activities.


Note list only includes students who have opted in.

Supervision Capacity and Current Project Availability 

I currently have capacity to supervise new Self-funded Postgraduate Researchers. To see available projects, please visit https://www.findaphd.com/phds/faculty-of-life-sciences/?c0g71Ug0 To apply online, complete our application form Complete Postgraduate Enquiry Form HERE

Teaching

Current teaching activities:
Programme Leader: Clinical Sciences 
Module Leader: CLS3006-C Chemistry, CLS5013-B Pharmacology and Therapeutics; INC7018-E Research Project

Professional activities

  • Fellow of the Higher Education Academy
  • University of Cambridge - PhD
  • University of Cambridge - MSci

  • University of Bradford - RCUK Academic Fellow in Medicinal Chemistry (1 January 2007)
  • The University of Manchester - Postdoctoral Research Associate (1 January 2004)

Publications